Also trades as: SIGHT.PA (PAR) · $vol 0M
GSGTF OTC
GenSight Biologics S.A.
1W: -11.1%
1M: -11.1%
3M: -11.1%
YTD: -57.9%
1Y: -57.9%
3Y: -97.5%
5Y: -98.9%
$0.08
-0.01 (-11.11%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1000
-99.9% ▼
5Y CAGR: -81.3%
Gross Profit
$0
-100.0% ▼
Operating Income
-$12M
+26.0% ▲
Net Income
-$12M
+14.1% ▲
EPS (Diluted)
$-0.08
+52.2% ▲
EBITDA
-$11M
+1.2% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $5M | $3M | $1M | $2M | $1000 |
| YoY Growth | +20.1% | -51.1% | -50.9% | +18.4% | -99.9% |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $5M | $3M | $1M | $2M | $0 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% |
| R&D Expenses | $23M | $19M | $19M | $12M | $6M |
| SG&A Expenses | $6M | $8M | $7M | $4M | $5M |
| Operating Expenses | $33M | $30M | $31M | $17M | $11M |
| Operating Income | -$28M | -$28M | -$30M | -$16M | -$12M |
| Operating Margin | -533.1% | -1078.0% | -2343.8% | -1054.2% | -1170494.6% |
| Interest Expense | $2M | $3M | $3M | $2M | $987K |
| Income Before Tax | -$29M | -$28M | -$28M | -$14M | -$12M |
| Tax Expense | $2K | $5K | -$2M | $21K | $5K |
| Net Income | -$29M | -$28M | -$26M | -$14M | -$12M |
| Net Margin | -542.4% | -1069.9% | -2069.5% | -933.4% | -1203594.4% |
| EPS (Diluted) | $-0.63 | $-0.60 | $-0.54 | $-0.17 | $-0.08 |
| EBITDA | -$27M | -$27M | -$21M | -$11M | -$11M |
| Shares Outstanding | 45M | 46M | 48M | 83M | 148M |